A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9
about
Hyperfractionated or accelerated radiotherapy for head and neck cancerInterventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapyA meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.The provision of enteral nutritional support during definitive chemoradiotherapy in head and neck cancer patientsThe current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neckIn silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroidsProliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice.Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-Can an online clinical data management service help in improving data collection and data quality in a developing country setting?Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer.Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis.Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocolsPre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy.Late term tolerance in head neck cancer patients irradiated in the IMRT era.Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck.Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation studyChemotherapy advances in locally advanced head and neck cancerParotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapy.Are cancer stem cells radioresistant?Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancersTechnical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy.Advances in radiochemotherapy in the treatment of head and neck cancer.Radioresistant laryngeal cancer: beyond the TNM stage.Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: Phase Ib studyRadiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.A long-term follow-up study after split-course irradiation with concurrent chemotherapy (carboplatin) for locally advanced head and neck cancer and a review of the literature.Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).Review of current treatment practices for carcinoma of the head and neck.Head and neck squamous cell carcinoma: optimizing the therapeutic index.Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity.0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers.Intensity-modulated radiation therapy in the treatment of head and neck cancer.Future chemotherapy and radiotherapy options in head and neck cancer.Radiotherapeutic management of locally advanced head and neck cancer.Clinical applications of proton radiation treatment at Loma Linda University: review of a fifteen-year experience.
P2860
Q24235527-016BF055-6DB0-4A95-8549-FF82B315B2E3Q24235741-B149E07E-0EE1-46C1-B3DF-55952A92E6C7Q25255831-BFB436AE-07A7-40A1-92A2-8F0723B6AA09Q26741905-FDBC8F27-03FD-4480-9730-431F47640193Q26830495-073AB8F3-AFEB-4A61-8222-50019DD12593Q28535111-26B3BE69-F585-4ACB-A275-9915D061C3E4Q33193703-1159C0AE-8D48-4FFE-9EA4-1A4FE74AD9D6Q33906160-50421917-03FD-4FCE-98F9-1BEE2B37A617Q33985369-B6C8DC98-F861-4D52-9460-775E0428E601Q34210492-B5E33649-9EA2-495E-B1A9-49E87D033A74Q34278528-FACF944A-FCA2-4730-A143-76A4B4EAED6DQ34299445-F6F860F3-D0B4-4E4B-A41A-8BE3BD76F59FQ34346429-F45FE1EE-3A02-42EC-A9DA-715529F301F1Q34439989-309B0BBC-0162-4699-98B8-0C2F506A722CQ34498186-E4BD3A95-CE24-485F-B819-59F5EF73FC37Q34561555-0F38B6E9-5802-491A-9C85-E5028282A296Q34610601-9EE2BD15-7B62-4D32-80F2-42E23559A5D7Q34657763-1F98194B-D20C-46C9-98A9-0C28A3A06DF3Q34680837-0A2324C1-EC1D-4A3E-B82D-FDC8C46D24EDQ34686233-D45520B1-3299-446D-83B7-8530BA3192BAQ35142863-6CCCFD17-5C73-40E6-A615-E2E0C324596DQ35534813-65D50C19-CD42-4697-9BA9-4B0953409179Q35602115-6ABF1BBC-857E-46B6-8BCB-383BC09BCBE4Q35653751-21F2A8D9-6189-449E-89FA-FA408542FA25Q35695543-91AEE5E9-AFAE-4F2E-9C16-185E3E6F576BQ35758264-49A0DF60-79A8-419D-B310-93775BEE5074Q35835166-9360B4D5-AE85-4526-818B-B35667E7D278Q35842215-4B2A5039-8A4F-4190-8906-5E475877B0B9Q35930366-98B00290-8A34-4995-923F-AA1F9BDB26C8Q36019202-EDCCA164-852B-4179-B99F-E8623CBEABADQ36080860-6A9CE15E-52ED-4676-A324-4F9E2DBF6F5DQ36163978-6BBC3164-89B9-4F92-94E1-63B58BDC6316Q36185629-14D30F3A-3BB0-4F8E-9117-4396793DFF00Q36185717-66405530-E150-44E2-9810-D5CEB9249B54Q36200146-9CAE15FA-3A2F-4390-B234-D6742EC9B0DBQ36235509-26FA1AFE-5BAC-4D2B-B20B-9FE98C7716BAQ36303901-5A1F043F-4DEC-4646-B1FF-CC0416A0917EQ36407462-D120D99D-2795-484D-950D-AF8677051E39Q36407464-8DF05192-CBD6-4FC9-A41E-47EA0A3E7BBAQ36427221-28881634-C91D-4A48-8F8D-DE00A35E9CC1
P2860
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9
description
article
@en
im August 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2000
@uk
ലേഖനം
@ml
name
A radiation therapy oncology g ...... inomas: first report of RTOG 9
@en
A radiation therapy oncology group
@nl
type
label
A radiation therapy oncology g ...... inomas: first report of RTOG 9
@en
A radiation therapy oncology group
@nl
prefLabel
A radiation therapy oncology g ...... inomas: first report of RTOG 9
@en
A radiation therapy oncology group
@nl
P2093
P1476
A Radiation Therapy Oncology G ...... mas: first report of RTOG 9003
@en
P2093
A S Garden
J S Cooper
S A Spencer
T L Phillips
P356
10.1016/S0360-3016(00)00663-5
P407
P577
2000-08-01T00:00:00Z